ArticlesCustomer StoriesEducation CornerFeatured StoriesGeneral Interest

Learning in their DNA: Inside the Bio-Rad Science Ambassador Program

Take a closer look at Bio-Rad’s initiative to bring scientists into K–12 schools in North America by following three Ambassadors as they go into classrooms. Find out more about what this program offers students, teachers, and researchers.
READ MORE →
ArticlesChromatographyCustomer Stories

Investigating Protein Translation with Bio-Rad’s NGC Chromatography System

The Fraser Laboratory in the Dept. of Molecular and Cellular Biology at UC Davis studies protein translation mechanisms by purifying diverse ribosomal proteins and reconstructing the translation complex in vitro. The lab utilized Bio-Rad’s NGC system to overcome specific purification difficulties with their protein while beta-testing the equipment. The NGC system enabled the group to increase their throughput by 25% and also saved substantial training time.
READ MORE →
ArticlesCustomer StoriesReal-time qPCR/PCR

Amplifying in the Outback: Researcher Brings Real-Time PCR to Australia’s Kimberley Wilderness

Dr. Tim Inglis of the University of Western Australia seeks better ways to conduct surveillance and respond to outbreaks of tropical infectious diseases. For over a decade he’s been developing detection assays for a slate of pathogens. Find out how Bio-Rad’s MiniOpticon Real-Time PCR system allows him to effectively run these assays in such remote locations as the Kimberley Wilderness in Australia’s Top End.
READ MORE →
ArticlesCustomer StoriesElectrophoresis/Western Blotting

TGX Stain-Free™ Precast Gels Facilitate LDL Research on Potential New Drug Targets

When Dr. Fred Bauzon started his research, he worked with bioinformatics specialists to functionalize suitable gene candidates based on their expression levels with HMGCR transcript levels. All his experiments demonstrated a reduction in low-density lipoprotein receptor protein (LDLR) and candidate gene protein levels after the candidate gene was silenced. Here Bauzon discusses how TGX Stain-free precast gels have aided his research toward future drug targets for the therapeutic control of LDL uptake.
READ MORE →
ArticlesBio-Plex Multiplex AssaysCustomer Stories

High Sensitivity of Bio-Plex® Multiplex System is Key in Study for Novel Melanoma Therapeutics

alt Melanoma is an aggressive cancer where early detection is essential for patient survival. The Facchiano lab is developing new anti-proliferation molecules against melanoma and is working to identify new molecular markers at the very early stages of pathology. Here Dr Antonio Facchiano discusses the merits of using the Bio-Plex technology to measure dose-dependent changes in expression levels of growth and angiogenic factors in cell lysates and supernatants.
READ MORE →
ArticlesCustomer StoriesDroplet Digital PCR (ddPCR)

Droplet Digital PCR Opens New Perspectives in HIV Research

Sangamo BioSciences, Inc., located in Richmond, California, is developing HIV therapeutics toward a functional cure using their proprietary zinc finger DNA-binding protein technology. Droplet digital PCR (ddPCR™) — or third generation PCR — offers a superior solution as it can detect target sequence within a single molecule, making it a powerful technology for low copy event detection.
READ MORE →
ArticlesCustomer StoriesReal-time qPCR/PCR

Novel HRM Assays Expedite Drug Resistance Surveillance for Leprosy Research

The significant drop in leprosy worldwide is attributed to the development of antimicrobial multidrug therapy (MDT). Resistance to rifampicin — the backbone of MDT treatment — has appeared. Controlling leprosy transmission requires routine surveillance for mutations in the drug target genes before, during, and after the course of treatment. New high resolution melt (HRM) assays offer leprosy researchers a faster, more economical method to investigate resistance targets.
READ MORE →
ArticlesBio-Plex Multiplex AssaysCustomer Stories

Bio-Plex® System in Korea — Seeking to Improve Outcomes for Cancer Patients

Dr Hunseok Lee has known since childhood that he wanted to grow up to become a scientist. “You get to wear white gowns, look through a microscope at various substances so small they can’t be seen by the naked eye — those things were very attractive to me when I was young,” says Lee. But the realities of putting research into practice and translating ideas into experiments have proven far more strenuous than the young Lee anticipated.
READ MORE →
ArticlesBio-Plex Multiplex AssaysCustomer Stories

Identifying Cardiac Defect–Related Protein Signatures

Identifying Cardiac Defect–Related Protein SignaturesAugust 15, 2011 “The first opportunity I had to lay my hand on a human heart I knew that was that — I knew that I wanted to know how the heart works, but more importantly, how it doesn’t work,” says Dr Francis Spinale, describing his inspiration to both research and treat cardiac disease. Using the Bio-Plex® suspension array system, researchers in his laboratory are discovering protein signatures that have the potential to inform decision strategies in cardiac patient treatment.
READ MORE →
ArticlesBio-Plex Multiplex AssaysCustomer Stories

Chemokines and Cytokines as Potential Markers for Personalizing Leukemia Treatment

Dr. Steven Kornblau has been on faculty at MD Anderson Cancer Center in Houston, Texas, for 20 years, where he divides his time between research into further understanding leukemia disease states, and a clinical practice where he treats a small number of patients with the disease. Recently, his laboratory used the Bio-Plex® suspension array system to discover how cytokine and chemokine profiles alone can be prognostic for patients with the disease, and therefore have to potential to assist development of personalized treatments.
READ MORE →